What is the long-term trend for National Healthcare's equity in earnings (losses) of equity method investees?

Over 3 years (2021 to 2024), National Healthcare's equity in earnings (losses) of equity method investees has grown at a -52.0% compound annual growth rate (CAGR), from $5.32M to $589K.

National Healthcare NHC Equity in earnings (losses) of equity method investees

Equity in earnings (losses) of equity method investees at other companies

Elevance HealthELV

$305M+142%

Option Care Health, Inc.OPCH

——

Sabra HealthcareSBRA

——

WelltowerWELL

——

American Healthcare REITAHR

——

Other financials

Income statement

See full

Revenue$381.8M+2.2%

Net income$36.1M+11.8%

Balance sheet

See full

Cash & equivalents$85.5M-5.4%

Total debt$39.3M-80.6%

Total equity$1.1B+8.6%

Total assets$1.5B-1.6%

Cash flow

See full

Operating cash flow$62.5M+59.3%

CapEx$9.6M+57.1%

Free cash flow$52.9M+59.7%

Valuation

See full

Market cap$3.12B+73.0%

Enterprise value$3.07B+57.4%

P/E24.7×+8.0×

P/S2×+0.7×

Profitability

See full

Net margin8.3%+0.5pp

FCF margin11%+3.2pp

Returns & leverage

See full

Return on equity12.1%+0.9pp

Debt / equity0×-0.2×

Current ratio1.9×0.0×

Where this comes from

Reported directly by National Healthcare in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromEquityMethodInvestments.

The official record: National Healthcare’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about National Healthcare's equity in earnings (losses) of equity method investees.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is National Healthcare's equity in earnings (losses) of equity method investees?: National Healthcare (NHC) reported equity in earnings (losses) of equity method investees of -$346K in Q1 2026.
What is the long-term trend for National Healthcare's equity in earnings (losses) of equity method investees?: Over 3 years (2021 to 2024), National Healthcare's equity in earnings (losses) of equity method investees has grown at a -52.0% compound annual growth rate (CAGR), from $5.32M to $589K.